I-287   Click here for help

GtoPdb Ligand ID: 12491

Compound class: Synthetic organic
Comment: I-287 is a protease-activated receptor-2 (PAR2) negative allosteric modulator [1]. It antagonises PAR2-mediated activation of Gq and G12/13 but not Gi/o proteins. It is one of the chemical compounds that were claimed in Vertex Pharmaceuticals (now abandoned) patent US20180057505A1.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 8
Hydrogen bond donors 1
Rotatable bonds 6
Topological polar surface area 94.8
Molecular weight 565.04
XLogP 3.8
No. Lipinski's rules broken 1
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES CC(C)(C)C1=C2C(=NC(=C1)C3=CC(=C(C=C3)Cl)F)C=C(C(=O)N4CCN(CC4(C)C)C5=CC=C(C=N5)C(=O)O)O2
Isomeric SMILES CC(C)(C)C1=CC(=NC2=C1OC(=C2)C(=O)N3CCN(CC3(C)C)C4=CC=C(C=N4)C(O)=O)C5=CC=C(Cl)C(F)=C5
InChI InChI=1S/C30H30ClFN4O4/c1-29(2,3)19-13-22(17-6-8-20(31)21(32)12-17)34-23-14-24(40-26(19)23)27(37)36-11-10-35(16-30(36,4)5)25-9-7-18(15-33-25)28(38)39/h6-9,12-15H,10-11,16H2,1-5H3,(H,38,39)
InChI Key WPJYZCYPCSYODL-UHFFFAOYSA-N
References
1. Avet C, Sturino C, Grastilleur S, Gouill CL, Semache M, Gross F, Gendron L, Bennani Y, Mancini JA, Sayegh CE et al.. (2020)
The PAR2 inhibitor I-287 selectively targets Gαq and Gα12/13 signaling and has anti-inflammatory effects.
Commun Biol, 3 (1): 719. [PMID:33247181]